Target intelligence / Profile preview

FXYD domain-containing ion transport regulator 1 (FXYD1)

Target
FXYD1
Molecular classification
Transmembrane regulatory protein, Na,K-ATPase accessory subunit, Other (specifically, member of the FXYD family of small membrane proteins)
01

Overview

FXYD domain-containing ion transport regulator 1 (FXYD1), also known as phospholemman (PLM), is a small single-span transmembrane protein highly expressed in heart, skeletal muscle, and brain. It is a principal regulatory subunit of the Na,K-ATPase, the enzyme responsible for maintaining cellular sodium and potassium gradients, crucial for electrical excitability and muscle contraction. FXYD1 modulates the affinity and activity of Na,K-ATPase for sodium and potassium ions in a tissue-specific and physiological-state-dependent manner. Its function is finely regulated by phosphorylation at conserved serines (Ser63, Ser68) by kinases such as PKA and PKC, leading to conformational changes that alter pump activity and thus ionic homeostasis. While not a direct receptor or enzyme, FXYD1 is a therapeutic target as a modulator of a critical ion transporter implicated in cardiovascular pathology, particularly heart failure, by influencing cardiac contractility and response to hormonal signaling. FXYD1’s dysfunction or altered regulation may contribute to disturbed ion homeostasis in disease states including cardiac arrhythmias and heart failure, and it may also be involved secondarily in cancer and metabolic disease by influencing overall Na,K-ATPase function.

Other names
PhospholemmanPLMSodium/potassium-transporting ATPase subunit FXYD1FXYD domain-containing ion transport regulator 1sodium/potassium-transporting ATPase subunit FXYD1
02

Mechanism of action

Allosteric modulation of Na,K-ATPase by direct protein–protein interaction. Regulatory phosphorylation by PKA and PKC alters its activity and its interaction with Na,K-ATPase α subunit.

03

Biological functions

Regulation of Na,K-ATPase activityModulation of ion transportSignal transduction (via phosphorylation-dependent mechanisms)
04

Disease associations

Cardiovascular disease (notably heart failure)Other (disturbance of Na,K-ATPase function may contribute to diabetes and cancer, though evidence specific to FXYD1 is limited)
05

Safety considerations

No direct drug-targeting safety concerns identified. As a modulator, targeting FXYD1 could theoretically dysregulate sodium/potassium homeostasis and cardiac contractility.
06

Interacting drugs

None directly approved or widely recognized as acting on FXYD1. (FXYD1 modulates targets of cardiac glycosides such as digoxin, but is not the direct drug-binding site.)
07

Biomarkers

Phosphorylated FXYD1/Phospholemman levels (used experimentally for cardiac signaling or muscle function, not established for clinical patient selection)

Beyond the preview

Go deeper on FXYD domain-containing ion transport regulator 1 (FXYD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FXYD domain-containing ion transport regulator 1 (FXYD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call